The emerging role of oral idarubicin in cancer chemotherapy: a seminar in print
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Auckland [u.a.]
Adis Internat.
1995
|
| Schriftenreihe: | Clinical drug investigation / Supplement
9,2 |
| Schlagworte: | |
| Beschreibung: | 60 S. graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV010929732 | ||
| 003 | DE-604 | ||
| 005 | 19980313 | ||
| 007 | t | ||
| 008 | 960904s1995 d||| |||| 10||| eng d | ||
| 035 | |a (OCoLC)35149546 | ||
| 035 | |a (DE-599)BVBBV010929732 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-355 | ||
| 245 | 1 | 0 | |a The emerging role of oral idarubicin in cancer chemotherapy |b a seminar in print |c guest ed.: H. T. Mouridsen |
| 264 | 1 | |a Auckland [u.a.] |b Adis Internat. |c 1995 | |
| 300 | |a 60 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Clinical drug investigation / Supplement |v 9,2 | |
| 650 | 7 | |a Chemotherapie |2 gtt | |
| 650 | 7 | |a Idarubicine |2 gtt | |
| 650 | 4 | |a Antineoplastic antibiotics |x Physiological effect | |
| 650 | 4 | |a Cancer |x Chemotherapy | |
| 650 | 4 | |a Daunomycin |x Physiological effect | |
| 650 | 4 | |a Daunomycin |x Therapeutic use | |
| 650 | 4 | |a Idarubicin |x pharmacology | |
| 650 | 4 | |a Idarubicin |x therapeutic use | |
| 650 | 4 | |a Neoplasms |x drug therapy | |
| 650 | 4 | |a Oral medication | |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Idarubicin |0 (DE-588)4356709-5 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 0 | 1 | |a Idarubicin |0 (DE-588)4356709-5 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Mouridsen, Henning Torbøl |e Sonstige |4 oth | |
| 810 | 2 | |a Supplement |t Clinical drug investigation |v 9,2 |w (DE-604)BV011640581 |9 9,2 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-007310954 | ||
Datensatz im Suchindex
| _version_ | 1804125419788566529 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV010929732 |
| ctrlnum | (OCoLC)35149546 (DE-599)BVBBV010929732 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01693nam a2200469 cb4500</leader><controlfield tag="001">BV010929732</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19980313 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">960904s1995 d||| |||| 10||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)35149546</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV010929732</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">The emerging role of oral idarubicin in cancer chemotherapy</subfield><subfield code="b">a seminar in print</subfield><subfield code="c">guest ed.: H. T. Mouridsen</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Auckland [u.a.]</subfield><subfield code="b">Adis Internat.</subfield><subfield code="c">1995</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">60 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Clinical drug investigation / Supplement</subfield><subfield code="v">9,2</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chemotherapie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Idarubicine</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic antibiotics</subfield><subfield code="x">Physiological effect</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Chemotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Daunomycin</subfield><subfield code="x">Physiological effect</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Daunomycin</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Idarubicin</subfield><subfield code="x">pharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Idarubicin</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oral medication</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Idarubicin</subfield><subfield code="0">(DE-588)4356709-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Idarubicin</subfield><subfield code="0">(DE-588)4356709-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mouridsen, Henning Torbøl</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="810" ind1="2" ind2=" "><subfield code="a">Supplement</subfield><subfield code="t">Clinical drug investigation</subfield><subfield code="v">9,2</subfield><subfield code="w">(DE-604)BV011640581</subfield><subfield code="9">9,2</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007310954</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Aufsatzsammlung Konferenzschrift |
| id | DE-604.BV010929732 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T18:01:16Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007310954 |
| oclc_num | 35149546 |
| open_access_boolean | |
| owner | DE-12 DE-355 DE-BY-UBR |
| owner_facet | DE-12 DE-355 DE-BY-UBR |
| physical | 60 S. graph. Darst. |
| publishDate | 1995 |
| publishDateSearch | 1995 |
| publishDateSort | 1995 |
| publisher | Adis Internat. |
| record_format | marc |
| series2 | Clinical drug investigation / Supplement |
| spelling | The emerging role of oral idarubicin in cancer chemotherapy a seminar in print guest ed.: H. T. Mouridsen Auckland [u.a.] Adis Internat. 1995 60 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Clinical drug investigation / Supplement 9,2 Chemotherapie gtt Idarubicine gtt Antineoplastic antibiotics Physiological effect Cancer Chemotherapy Daunomycin Physiological effect Daunomycin Therapeutic use Idarubicin pharmacology Idarubicin therapeutic use Neoplasms drug therapy Oral medication Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Idarubicin (DE-588)4356709-5 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content (DE-588)1071861417 Konferenzschrift gnd-content Krebs Medizin (DE-588)4073781-0 s Idarubicin (DE-588)4356709-5 s DE-604 Mouridsen, Henning Torbøl Sonstige oth Supplement Clinical drug investigation 9,2 (DE-604)BV011640581 9,2 |
| spellingShingle | The emerging role of oral idarubicin in cancer chemotherapy a seminar in print Chemotherapie gtt Idarubicine gtt Antineoplastic antibiotics Physiological effect Cancer Chemotherapy Daunomycin Physiological effect Daunomycin Therapeutic use Idarubicin pharmacology Idarubicin therapeutic use Neoplasms drug therapy Oral medication Krebs Medizin (DE-588)4073781-0 gnd Idarubicin (DE-588)4356709-5 gnd |
| subject_GND | (DE-588)4073781-0 (DE-588)4356709-5 (DE-588)4143413-4 (DE-588)1071861417 |
| title | The emerging role of oral idarubicin in cancer chemotherapy a seminar in print |
| title_auth | The emerging role of oral idarubicin in cancer chemotherapy a seminar in print |
| title_exact_search | The emerging role of oral idarubicin in cancer chemotherapy a seminar in print |
| title_full | The emerging role of oral idarubicin in cancer chemotherapy a seminar in print guest ed.: H. T. Mouridsen |
| title_fullStr | The emerging role of oral idarubicin in cancer chemotherapy a seminar in print guest ed.: H. T. Mouridsen |
| title_full_unstemmed | The emerging role of oral idarubicin in cancer chemotherapy a seminar in print guest ed.: H. T. Mouridsen |
| title_short | The emerging role of oral idarubicin in cancer chemotherapy |
| title_sort | the emerging role of oral idarubicin in cancer chemotherapy a seminar in print |
| title_sub | a seminar in print |
| topic | Chemotherapie gtt Idarubicine gtt Antineoplastic antibiotics Physiological effect Cancer Chemotherapy Daunomycin Physiological effect Daunomycin Therapeutic use Idarubicin pharmacology Idarubicin therapeutic use Neoplasms drug therapy Oral medication Krebs Medizin (DE-588)4073781-0 gnd Idarubicin (DE-588)4356709-5 gnd |
| topic_facet | Chemotherapie Idarubicine Antineoplastic antibiotics Physiological effect Cancer Chemotherapy Daunomycin Physiological effect Daunomycin Therapeutic use Idarubicin pharmacology Idarubicin therapeutic use Neoplasms drug therapy Oral medication Krebs Medizin Idarubicin Aufsatzsammlung Konferenzschrift |
| volume_link | (DE-604)BV011640581 |
| work_keys_str_mv | AT mouridsenhenningtorbøl theemergingroleoforalidarubicinincancerchemotherapyaseminarinprint |